Literature DB >> 5470086

Hepatitis-associated antigen and antibody in haemodialysis patients and staff.

A H Knight, R A Fox, R A Baillod, S P Niazi, S Sherlock, J F Moorhead.   

Abstract

The screening of a dialysis population for the presence of hepatitis-associated antigen (H.A. antigen) has proved to be of value in locating a probable source of infection and in terminating an outbreak of hepatitis by early detection of H.A. antigen positive patients and staff.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5470086      PMCID: PMC1701754          DOI: 10.1136/bmj.3.5723.603

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Eight months' experience with silastic-teflon bypass cannulas.

Authors:  W E QUINTON; D H DILLARD; J J COLE; B H SCRIBNER
Journal:  Trans Am Soc Artif Intern Organs       Date:  1962

2.  Viral hepatitis. A staff hazard in dialysis units.

Authors:  P O Jones; H J Goldsmith; F K Wright; C Roberts; D C Watson
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

3.  Relation of Australia and SH antigens.

Authors:  A M Prince
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

4.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

5.  S.H. antigen in haemodialysis-associated hepatitis.

Authors:  G C Turner; G B White
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

6.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

7.  Automated determination of serum glutamic oxaloacetic transaminase.

Authors:  S Morgenstern; M Oklander; J Auerbach; J Kaufman; B Klein
Journal:  Clin Chem       Date:  1966-02       Impact factor: 8.327

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

9.  Hepatitis and leukemia: their relation to Australia antigen.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Bull N Y Acad Med       Date:  1968-12

10.  Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.

Authors:  M J Brescia; J E Cimino; K Appel; B J Hurwich
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

View more
  10 in total

Review 1.  Immunological reactivity and viral hepatitis.

Authors:  S Sherlock
Journal:  Bull N Y Acad Med       Date:  1975-04

Review 2.  Long-incubation (virus B, HAA-associated) hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

3.  Screening for transmission of hepatitis within a liver unit.

Authors:  P Bentley; D Haynes; P Sharpstone; P E Taylor; A J Zuckerman; R Williams
Journal:  J Hyg (Lond)       Date:  1972-03

4.  Epidemiology of COVID-19 in an Urban Dialysis Center.

Authors:  Richard W Corbett; Sarah Blakey; Dorothea Nitsch; Marina Loucaidou; Adam McLean; Neill Duncan; Damien R Ashby
Journal:  J Am Soc Nephrol       Date:  2020-06-19       Impact factor: 10.121

5.  An epidemic of hepatitis in a renal dialysis unit.

Authors:  R A Fox; A H Knight; S P Niazi; S Sherlock; R A Baillod; J F Moorhead
Journal:  Proc R Soc Med       Date:  1971-03

6.  Hepatitis and its problems in a haemodialysis Unit.

Authors:  L Váry; A Karátson; S Köves; J Juhász
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

7.  The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.

Authors:  R A Fox; F J Dudley; S Sherlock
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

8.  Cytomegalovirus hepatitis in an artificial kidney unit.

Authors:  S Larsson; M Ekberg; T Denneberg
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

9.  Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil.

Authors:  Lia L Lewis-Ximenez; Kycia M R do O; Cleber F Ginuino; Jucimara C Silva; Hermann G Schatzmayr; Sherri Stuver; Clara F T Yoshida
Journal:  BMC Public Health       Date:  2002-11-22       Impact factor: 3.295

10.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.